Science Explorer Back to mapMap
Discussion
Company · Changzhou · China

LipidALL Technologies (China)

Research works
17
▲ 66% vs 2018-21
Citations
636
37.8 per fractional work
Top-10% rate
26.7%
all institutions 10.0%
Open access
74%
world 40%
International
23%
world 18%

Not ranked overall: LipidALL Technologies (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does LipidALL Technologies (China) work in?

In all years, 62% of research at LipidALL Technologies (China) is in Life Sciences, 31% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (46%), Medicine (29%), Neuroscience (8%). It does 2.4× the world's share of Life Sciences.

Life Sciences: 10 fractional works · 61.6% of its workBiochemistry, Genetics and Molecular Biology: 8 fractional works · 45.7% of its workMolecular Biology: 5 fractional works · 29.4% of its workBiochemistry: 1 fractional works · 5.1% of its workCancer Research: 1 fractional works · 3.4% of its workCell Biology: 0 fractional works · 2.7% of its workGenetics: 0 fractional works · 1.4% of its workAging: 0 fractional works · 1.2% of its workClinical Biochemistry: 0 fractional works · 1.1% of its workStructural Biology: 0 fractional works · 0.7% of its workPhysiology: 0 fractional works · 0.5% of its workBiotechnology: 0 fractional works · 0.3% of its workNeuroscience: 1 fractional works · 8.3% of its workDevelopmental Neuroscience: 0 fractional works · 2.3% of its workNeurology: 0 fractional works · 2.3% of its workEndocrine and Autonomic Systems: 0 fractional works · 1.8% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.2% of its workCognitive Neuroscience: 0 fractional works · 0.4% of its workBehavioral Neuroscience: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 1 fractional works · 5.2% of its workAgronomy and Crop Science: 1 fractional works · 3.2% of its workPlant Science: 0 fractional works · 1.4% of its workAnimal Science and Zoology: 0 fractional works · 0.7% of its workImmunology and Microbiology: 0 fractional works · 2.3% of its workImmunology: 0 fractional works · 2.1% of its workVirology: 0 fractional works · 0.2% of its workHealth Sciences: 5 fractional works · 31.5% of its workMedicine: 5 fractional works · 29.0% of its workPhysiology: 1 fractional works · 8.2% of its workEpidemiology: 1 fractional works · 5.1% of its workSurgery: 0 fractional works · 2.6% of its workReproductive Medicine: 0 fractional works · 1.8% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.8% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.4% of its workNephrology: 0 fractional works · 1.1% of its workPathology and Forensic Medicine: 0 fractional works · 1.1% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.9% of its workEmergency Medicine: 0 fractional works · 0.8% of its workComplementary and alternative medicine: 0 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.7% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.7% of its workGeriatrics and Gerontology: 0 fractional works · 0.6% of its workRheumatology: 0 fractional works · 0.5% of its workInfectious Diseases: 0 fractional works · 0.4% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 2.5% of its workNutrition and Dietetics: 0 fractional works · 2.5% of its workPhysical Sciences: 1 fractional works · 7.0% of its workChemistry: 1 fractional works · 4.8% of its workSpectroscopy: 1 fractional works · 3.8% of its workAnalytical Chemistry: 0 fractional works · 0.7% of its workOrganic Chemistry: 0 fractional works · 0.3% of its workEngineering: 0 fractional works · 0.8% of its workBiomedical Engineering: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEnvironmental Science: 0 fractional works · 0.6% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.4% of its workGlobal and Planetary Change: 0 fractional works · 0.3% of its workEnergy: 0 fractional works · 0.5% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.5% of its workEarth and Planetary Sciences: 0 fractional works · 0.3% of its workPaleontology: 0 fractional works · 0.3% of its workALL ITS WORKLipidALLTechnologies…17fractional works, all years
Life Sciences62%Physical Sciences7%Health Sciences31%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 11 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology845.7%
    2. Neuroscience18.3%
    3. Agricultural and Biological Sciences15.2%
    4. Immunology and Microbiology02.3%
    1. Medicine529.0%
    2. Nursing02.5%
    1. Chemistry14.8%
    2. Engineering00.8%
    3. Environmental Science00.6%
    4. Energy00.5%
    5. Earth and Planetary Sciences00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.60× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 7.69× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 2.24× its world share, 0 worksImmunology and Micro…Neuroscience: 7.04× its world share, 1 worksNeuroscienceChemistry: 1.12× its world share, 0 worksChemistryEarth and Planetary Sciences: 0.29× its world share, 0 worksEarth and Planetary …Environmental Science: 0.20× its world share, 0 worksEnvironmental ScienceMedicine: 1.67× its world share, 3 worksMedicineNursing: 4.81× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.7×. Every wedge is a field page.

All 9 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology7.69×4 works
  2. Neuroscience7.04×1 works
  3. Nursing4.81×0 works
  4. Immunology and Microbiology2.24×0 works
  5. Medicine1.67×3 works
  6. Agricultural and Biological Sciences1.60×1 works
  7. Chemistry1.12×0 works
  8. Earth and Planetary Sciences0.29×0 works
  9. Environmental Science0.20×0 works

Who are the top researchers at LipidALL Technologies (China)?

Ranked on the quality score, Bowen Li lead among researchers whose main affiliation is LipidALL Technologies (China).

  1. 1 Bowen Li China · #638,558 worldwide 1.8k citations · 57 works
All ranked researchers at LipidALL Technologies (China)

What are the most cited papers from LipidALL Technologies (China)?

The most cited paper from LipidALL Technologies (China) is "Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis" (Jin‐Wen Song et al., 2020), with 548 citations. Next come "Integration of lipidomics and metabolomics for in-depth understanding of cellular mechanism and disease progression" (343) and "A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19" (313).

Most cited papers
#PaperReleasedCitations
1 Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis Jin‐Wen Song et al. · Cell Metabolism Open access 24 Jun 2020 548
2 Integration of lipidomics and metabolomics for in-depth understanding of cellular mechanism and disease progression Raoxu Wang, Bowen Li, Sin Man Lam et al. · Journal of genetics and genomics/Journal of Genetics and Genomics 18 Dec 2019 343
3 A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19 Sin Man Lam et al. · Nature Metabolism Open access 22 Jun 2021 313
4 RIPK3 Orchestrates Fatty Acid Metabolism in Tumor-Associated Macrophages and Hepatocarcinogenesis Lei Wu, Xiao Zhang, Lu Zheng et al. · Cancer Immunology Research 2 Mar 2020 285
5 Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury Zhongyuan Bao, Yinlong Liu, Binglin Chen et al. · Nature Communications Open access 9 Jul 2021 147
All 61 most cited papers, with filters and sorting

Which research topics does LipidALL Technologies (China) publish most on?

By volume in 2022-now: Metabolomics and Mass Spectrometry Studies, Sphingolipid Metabolism and Signaling, Autophagy in Disease and Therapy and Neurogenesis and neuroplasticity mechanisms.

  1. 1 Metabolomics and Mass Spectrometry Studies Molecular Biology 1 works
  2. 2 Sphingolipid Metabolism and Signaling Molecular Biology 1 works
  3. 3 Autophagy in Disease and Therapy Epidemiology 0 works
  4. 4 Neurogenesis and neuroplasticity mechanisms Developmental Neuroscience 0 works
  5. 5 Neuroinflammation and Neurodegeneration Mechanisms Neurology 0 works
  6. 6 Lipid metabolism and biosynthesis Biochemistry 0 works
  7. 7 Reproductive Physiology in Livestock Agronomy and Crop Science 0 works
  8. 8 Fatty Acid Research and Health Nutrition and Dietetics 0 works
  9. 9 Mitochondrial Function and Pathology Molecular Biology 0 works
  10. 10 Diet and metabolism studies Physiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available74.0%not open26.0%

World: 40% of research is openly available.

with international co-authors23.0%domestic only77.0%

World: 18% is written across borders.

How has LipidALL Technologies (China)'s research output changed?

Output in 2022-2025 was 66% higher than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is LipidALL Technologies (China) as a percentage of every work published that year, 0.000038% in 2024.

still counting0.000020%0.000040%0.000060%LipidALL Technologies (China)0.000017% in 20252020

Fractional works of LipidALL Technologies (China) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Changzhou

All research institutions in Changzhou

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about LipidALL Technologies (China). Posts are plain text and can be reported.